{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:18:06Z","timestamp":1789409886390,"version":"build-2803163510"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T00:00:00Z","timestamp":1702080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100001453","name":"American Brain Tumor Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001021","name":"Damon Runyon Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001021","id-type":"DOI","asserted-by":"publisher"}]},{"name":"American Association for Cancer Research Breast Cancer Research Fellowship"},{"name":"American Society of Clinical Oncology Young Investigator Award"},{"name":"European Union\u2019s Horizon 2020 Programme: Marie Sk\u0142odowska-Curie","award":["844646-GLIOHAB"],"award-info":[{"award-number":["844646-GLIOHAB"]}]},{"name":"Spanish State Research Agency, Subprogram for Knowledge Generation","award":["PID2021-127110OA-I00"],"award-info":[{"award-number":["PID2021-127110OA-I00"]}]},{"DOI":"10.13039\/100001021","name":"Damon Runyon Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R21AG067562-01"],"award-info":[{"award-number":["1R21AG067562-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R21GM137227-01"],"award-info":[{"award-number":["1R21GM137227-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union\u2019s Horizon 2020 Programme: ERC Grant","award":["758657-ImPRESS"],"award-info":[{"award-number":["758657-ImPRESS"]}]},{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","award":["2016102"],"award-info":[{"award-number":["2016102"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","award":["2017073"],"award-info":[{"award-number":["2017073"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","award":["2013069"],"award-info":[{"award-number":["2013069"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008730","name":"Norwegian Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Council of Norway FRIPRO","award":["261984"],"award-info":[{"award-number":["261984"]}]},{"name":"Research Council of Norway FRIPRO","award":["303249"],"award-info":[{"award-number":["303249"]}]},{"name":"Research Council of Norway FRIPRO","award":["R01CA211238-01"],"award-info":[{"award-number":["R01CA211238-01"]}]},{"name":"Research Council of Norway FRIPRO","award":["R01CA244975"],"award-info":[{"award-number":["R01CA244975"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>We recently conducted a phase 2 trial (NCT028865685) evaluating intracranial efficacy of pembrolizumab for brain metastases (BM) of diverse histologies. Our study met its primary efficacy endpoint and illustrates that pembrolizumab exerts promising activity in a select group of patients with BM. Given the importance of aberrant vasculature in mediating immunosuppression, we explored the relationship between immune checkpoint inhibitor (ICI) efficacy and vascular architecture in the hopes of identifying potential mechanisms of intracranial ICI response or resistance for BM.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Using Vessel Architectural Imaging, a histologically validated quantitative metric for in vivo tumor vascular physiology, we analyzed dual-echo DSC\/DCE MRI for 44 patients on trial. Tumor and peri-tumor cerebral blood volume\/flow, vessel size, arterial and venous dominance, and vascular permeability were measured before and after treatment with pembrolizumab.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>BM that progressed on ICI were characterized by a highly aberrant vasculature dominated by large-caliber vessels. In contrast, ICI-responsive BM possessed a more structurally balanced vasculature consisting of both small and large vessels, and there was a trend toward a decrease in under-perfused tissue, suggesting a reversal of the negative effects of hypoxia. In the peri-tumor region, the development of smaller blood vessels, consistent with neo-angiogenesis, was associated with tumor growth before radiographic evidence of contrast enhancement on anatomical MRI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study, one of the largest functional imaging studies for BM, suggests that vascular architecture is linked with ICI efficacy. Studies identifying modulators of vascular architecture, and effects on immune activity, are warranted and may inform future combination treatments.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/neuonc\/noad236","type":"journal-article","created":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T18:25:37Z","timestamp":1702146337000},"page":"965-974","source":"Crossref","is-referenced-by-count":9,"title":["Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance"],"prefix":"10.1093","volume":"26","author":[{"given":"Albert E","family":"Kim","sequence":"first","affiliation":[{"name":"Massachusetts General Hospital Cancer Center, Harvard Medical School , Boston, Massachusetts , USA"},{"name":"Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin W","family":"Lou","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Cancer Center, Harvard Medical School , Boston, Massachusetts , USA"},{"name":"Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Giobbie-Hurder","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Chang","sequence":"additional","affiliation":[{"name":"Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital , Boston, Massachusetts , USA"},{"name":"Department of Radiology, Massachusetts General Hospital , Boston, Massachusetts , USA"},{"name":"Harvard Graduate Program in Biophysics, Harvard University , Cambridge, Massachusetts , USA"},{"name":"Massachusetts Institute of Technology , Cambridge, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mishka","family":"Gidwani","sequence":"additional","affiliation":[{"name":"Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Hoebel","sequence":"additional","affiliation":[{"name":"Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital , Boston, Massachusetts , USA"},{"name":"Harvard Graduate Program in Biophysics, Harvard University , Cambridge, Massachusetts , USA"},{"name":"Massachusetts Institute of Technology , Cambridge, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay B","family":"Patel","sequence":"additional","affiliation":[{"name":"Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital , Boston, Massachusetts , USA"},{"name":"Harvard Graduate Program in Biophysics, Harvard University , Cambridge, Massachusetts , USA"},{"name":"Massachusetts Institute of Technology , Cambridge, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mason C","family":"Cleveland","sequence":"additional","affiliation":[{"name":"Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveer","family":"Singh","sequence":"additional","affiliation":[{"name":"Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital , Boston, Massachusetts , USA"},{"name":"Department of Radiology, Massachusetts General Hospital , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P","family":"Bridge","sequence":"additional","affiliation":[{"name":"Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital , Boston, Massachusetts , USA"},{"name":"Department of Radiology, Massachusetts General Hospital , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Rakin","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital , Boston, Massachusetts , USA"},{"name":"Harvard Graduate Program in Biophysics, Harvard University , Cambridge, Massachusetts , USA"},{"name":"Massachusetts Institute of Technology , Cambridge, Massachusetts , USA"},{"name":"Geisel School of Medicine, Dartmouth College , Hanover, New Hampshire , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A","family":"Bearce","sequence":"additional","affiliation":[{"name":"Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Liu","sequence":"additional","affiliation":[{"name":"Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elies","family":"Fuster-Garcia","sequence":"additional","affiliation":[{"name":"Department of Physics and Computational Radiology, Division of Radiology & Nuclear Medicine, Oslo University Hospital , Oslo , Norway"},{"name":"Instituto Universitario de Tecnolog\u00edas de la Informaci\u00f3n y Comunicaciones, Universitat Polit\u00e8cnica de Val\u00e8ncia , Val\u00e8ncia , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eudocia Q","family":"Lee","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy U","family":"Lin","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Overmoyer","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick Y","family":"Wen","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi","family":"Nayak","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine V","family":"Cohen","sequence":"additional","affiliation":[{"name":"Abramson Cancer Center, University of Pennsylvania School of Medicine , Philadelphia, Pennsylvania , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorg","family":"Dietrich","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Cancer Center, Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Eichler","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Cancer Center, Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Heist","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Cancer Center, Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Krop","sequence":"additional","affiliation":[{"name":"Yale Cancer Center, Yale School of Medicine , New Haven, Connecticut , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Lawrence","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Cancer Center, Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Ligibel","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Tolaney","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Mayer","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Winer","sequence":"additional","affiliation":[{"name":"Yale Cancer Center, Yale School of Medicine , New Haven, Connecticut , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen M","family":"Perrino","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J","family":"Summers","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Cancer Center, Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Mahar","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Cancer Center, Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Oh","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Cancer Center, Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen A","family":"Shih","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Cancer Center, Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P","family":"Cahill","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Cancer Center, Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R","family":"Rosen","sequence":"additional","affiliation":[{"name":"Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital , Boston, Massachusetts , USA"},{"name":"Department of Radiology, Massachusetts General Hospital , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9986-5327","authenticated-orcid":false,"given":"Yi-Fen","family":"Yen","sequence":"additional","affiliation":[{"name":"Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital , Boston, Massachusetts , USA"},{"name":"Department of Radiology, Massachusetts General Hospital , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayashree","family":"Kalpathy-Cramer","sequence":"additional","affiliation":[{"name":"Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital , Boston, Massachusetts , USA"},{"name":"Department of Radiology, Massachusetts General Hospital , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Martinez-Lage","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Cancer Center, Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla K","family":"Brastianos","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Cancer Center, Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyrre E","family":"Emblem","sequence":"additional","affiliation":[{"name":"Department of Physics and Computational Radiology, Division of Radiology & Nuclear Medicine, Oslo University Hospital , Oslo , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth R","family":"Gerstner","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Cancer Center, Harvard Medical School , Boston, Massachusetts , USA"},{"name":"Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,12,9]]},"reference":[{"issue":"7","key":"2024050310211623800_CIT0001","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1038\/s41591-023-02392-7","article-title":"Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results","volume":"29","author":"Brastianos","year":"2023","journal-title":"Nat Med."},{"issue":"10","key":"2024050310211623800_CIT0002","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/s41593-018-0227-9","article-title":"CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature","volume":"21","author":"Louveau","year":"2018","journal-title":"Nat Neurosci."},{"issue":"7792","key":"2024050310211623800_CIT0003","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41586-019-1912-x","article-title":"VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours","volume":"577","author":"Song","year":"2020","journal-title":"Nature."},{"issue":"7","key":"2024050310211623800_CIT0004","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.4049\/jimmunol.1002961","article-title":"Common lymphatic endothelial and vascular endothelial receptor-1 mediates the transmigration of regulatory T cells across human hepatic sinusoidal endothelium","volume":"186","author":"Shetty","year":"2011","journal-title":"J Immunol."},{"issue":"6","key":"2024050310211623800_CIT0005","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nm.3541","article-title":"Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors","volume":"20","author":"Motz","year":"2014","journal-title":"Nat Med."},{"issue":"3","key":"2024050310211623800_CIT0006","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nrc3186","article-title":"Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity","volume":"12","author":"Swartz","year":"2012","journal-title":"Nat Rev Cancer."},{"issue":"11","key":"2024050310211623800_CIT0007","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1158\/2159-8290.CD-15-0369","article-title":"Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets","volume":"5","author":"Brastianos","year":"2015","journal-title":"Cancer Discov"},{"issue":"5","key":"2024050310211623800_CIT0008","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1470-2045(20)30111-X","article-title":"Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial","volume":"21","author":"Goldberg","year":"2020","journal-title":"Lancet Oncol."},{"issue":"3","key":"2024050310211623800_CIT0009","doi-asserted-by":"crossref","first-page":"e005583","DOI":"10.1136\/jitc-2022-005583","article-title":"Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice","volume":"11","author":"Dong","year":"2023","journal-title":"J ImmunoTher Cancer."},{"issue":"3","key":"2024050310211623800_CIT0010","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1549-8719.2010.00029.x","article-title":"Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre-clinical models","volume":"17","author":"Fukumura","year":"2010","journal-title":"Microcirculation."},{"issue":"17","key":"2024050310211623800_CIT0011","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1200\/JCO.2012.46.3653","article-title":"Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers","volume":"31","author":"Jain","year":"2013","journal-title":"J Clin Oncol."},{"issue":"3","key":"2024050310211623800_CIT0012","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/mrm.20383","article-title":"Vessel size imaging in humans","volume":"53","author":"Kiselev","year":"2005","journal-title":"Magn Reson Med."},{"issue":"4","key":"2024050310211623800_CIT0013","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/mrm.1910340412","article-title":"MR contrast due to intravascular magnetic susceptibility perturbations","volume":"34","author":"Boxerman","year":"1995","journal-title":"Magn Reson Med."},{"issue":"6","key":"2024050310211623800_CIT0014","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/mrm.1910400602","article-title":"NMR imaging of changes in vascular morphology due to tumor angiogenesis","volume":"40","author":"Dennie","year":"1998","journal-title":"Magn Reson Med."},{"issue":"9","key":"2024050310211623800_CIT0015","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/nm.3289","article-title":"Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy","volume":"19","author":"Emblem","year":"2013","journal-title":"Nat Med."},{"issue":"9","key":"2024050310211623800_CIT0016","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","article-title":"3D Slicer as an image computing platform for the Quantitative Imaging Network","volume":"30","author":"Fedorov","year":"2012","journal-title":"Magn Reson Imaging."},{"issue":"1","key":"2024050310211623800_CIT0017","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12021-020-09477-5","article-title":"DeepNeuro: an open-source deep learning toolbox for neuroimaging","volume":"19","author":"Beers","year":"2021","journal-title":"Neuroinformatics"},{"issue":"6","key":"2024050310211623800_CIT0018","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S1470-2045(15)70057-4","article-title":"Response assessment criteria for brain metastases: Proposal from the RANO group","volume":"16","author":"Lin","year":"2015","journal-title":"Lancet Oncol."},{"issue":"4","key":"2024050310211623800_CIT0019","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.adro.2018.05.005","article-title":"Brain metastases with poor vascular function are susceptible to pseudoprogression after stereotactic radiation surgery","volume":"3","author":"Digernes","year":"2018","journal-title":"Adv Radiat Oncol"},{"issue":"4","key":"2024050310211623800_CIT0020","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/mrm.1910340412","article-title":"MR contrast due to intravascular magnetic susceptibility perturbations","volume":"34","author":"Boxerman","year":"1995","journal-title":"Magn Reson Med."},{"issue":"22","key":"2024050310211623800_CIT0021","doi-asserted-by":"crossref","first-page":"225020","DOI":"10.1088\/1361-6560\/abb71a","article-title":"Noise dependency in vascular parameters from combined gradient-echo and spin-echo DSC MRI","volume":"65","author":"Digernes","year":"2020","journal-title":"Phys Med Biol."},{"issue":"16","key":"2024050310211623800_CIT0022","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1158\/1078-0432.CCR-23-0203","article-title":"Bavituximab decreases immunosuppressive myeloid-derived suppressor cells in newly diagnosed glioblastoma patients","volume":"29","author":"Ly","year":"2023","journal-title":"Clin Cancer Res."},{"issue":"1","key":"2024050310211623800_CIT0023","first-page":"1","article-title":"Vascular dysfunction promotes regional hypoxia after bevacizumab therapy in recurrent glioblastoma patients","volume":"2","author":"Gerstner","year":"2020","journal-title":"Neurooncol Adv"},{"issue":"1","key":"2024050310211623800_CIT0024","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13058-020-01372-w","article-title":"Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases","volume":"22","author":"Leone","year":"2020","journal-title":"Breast Cancer Res."},{"issue":"7","key":"2024050310211623800_CIT0025","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.3390\/cancers14071725","article-title":"Quantification of tissue compression identifies high-grade glioma patients with reduced survival","volume":"14","author":"Fuster-Garcia","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"6","key":"2024050310211623800_CIT0026","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1177\/0271678X17694187","article-title":"A theoretical framework for determining cerebral vascular function and heterogeneity from dynamic susceptibility contrast MRI","volume":"37","author":"Digernes","year":"2017","journal-title":"J Cereb Blood Flow Metab."},{"issue":"2","key":"2024050310211623800_CIT0027","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1158\/0008-5472.CAN-11-2464","article-title":"Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion","volume":"72","author":"Sorensen","year":"2012","journal-title":"Cancer Res."},{"issue":"10","key":"2024050310211623800_CIT0028","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrclinonc.2014.126","article-title":"Vessel caliber\u2014a potential MRI biomarker of tumour response in clinical trials","volume":"11","author":"Emblem","year":"2014","journal-title":"Nat Rev Clin Oncol."},{"issue":"4","key":"2024050310211623800_CIT0029","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/mrm.21193","article-title":"Assessment of the morphological and functional effects of the anti-angiogenic agent SU11657 on 9L gliosarcoma vasculature using dynamic susceptibility contrast MRI","volume":"57","author":"Quarles","year":"2007","journal-title":"Magn Reson Med."},{"issue":"4","key":"2024050310211623800_CIT0030","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1476-5586(03)80026-X","article-title":"Functional response of tumor vasculature to PaCO2: determination of total and microvascular blood volume by MRI","volume":"5","author":"Packard","year":"2003","journal-title":"Neoplasia"},{"issue":"1","key":"2024050310211623800_CIT0031","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40644-015-0039-z","article-title":"Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging","volume":"15","author":"Li","year":"2015","journal-title":"Cancer Imaging"},{"issue":"16","key":"2024050310211623800_CIT0032","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1073\/pnas.1525349113","article-title":"Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages","volume":"113","author":"Peterson","year":"2016","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"2024050310211623800_CIT0033","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ncponc0403","article-title":"Lessons from phase III clinical trials on anti-VEGF therapy for cancer","volume":"3","author":"Jain","year":"2006","journal-title":"Nat Clin Pract Oncol."},{"issue":"6","key":"2024050310211623800_CIT0034","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1007\/s00330-022-09164-w","article-title":"Vessel size and perfusion-derived vascular habitat refines prediction of treatment failure to bevacizumab in recurrent glioblastomas: validation in a prospective cohort","volume":"33","author":"Kim","year":"2022","journal-title":"Eur Radiol."},{"issue":"4","key":"2024050310211623800_CIT0035","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3174\/ajnr.A6984","article-title":"Vessel type determined by vessel architectural imaging improves differentiation between early tumor progression and pseudoprogression in glioblastoma","volume":"42","author":"Kim","year":"2021","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"2024050310211623800_CIT0036","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/cyt.12405","article-title":"Microvascular proliferation of brain metastases mimics glioblastomas in squash cytology","volume":"28","author":"Gi","year":"2017","journal-title":"Cytopathology."},{"issue":"12","key":"2024050310211623800_CIT0037","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.15252\/emmm.201607445","article-title":"Dynamic stroma reorganization drives blood vessel dysmorphia during glioma growth","volume":"9","author":"Mathivet","year":"2017","journal-title":"EMBO Mol Med."},{"issue":"2","key":"2024050310211623800_CIT0038","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijrobp.2013.07.022","article-title":"The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved","volume":"88","author":"Brown","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"6","key":"2024050310211623800_CIT0039","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s00415-009-5034-5","article-title":"Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence","volume":"256","author":"Hoefnagels","year":"2009","journal-title":"J Neurol."},{"issue":"1","key":"2024050310211623800_CIT0040","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ccr.2006.11.021","article-title":"AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients","volume":"11","author":"Batchelor","year":"2007","journal-title":"Cancer Cell"},{"issue":"16_suppl","key":"2024050310211623800_CIT0041","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1200\/JCO.2022.40.16_suppl.2030","article-title":"Phase 2 trial of bavituximab with chemoradiation and adjuvant temozolomide in newly diagnosed glioblastoma","volume":"40","author":"Ly","year":"2022","journal-title":"J Clin Oncol."},{"issue":"10","key":"2024050310211623800_CIT0042","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/neuonc\/nov119","article-title":"Editor\u2019s choice: Intratumoral heterogeneity in glioblastoma: don\u2019t forget the peritumoral brain zone","volume":"17","author":"LemCrossed","year":"2015","journal-title":"Neuro Oncol"},{"issue":"1","key":"2024050310211623800_CIT0043","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/2159-8290.CD-21-0291","article-title":"Characterization of the genomic and immunologic diversity of malignant brain tumors through multisector analysis","volume":"12","author":"Schaettler","year":"2022","journal-title":"Cancer Discov"},{"issue":"8","key":"2024050310211623800_CIT0044","doi-asserted-by":"crossref","first-page":"e0220939","DOI":"10.1371\/journal.pone.0220939","article-title":"Vessel architecture imaging using multiband gradient-echo\/spin-echo EPI","volume":"14","author":"Zhang","year":"2019","journal-title":"PLoS One."},{"issue":"8","key":"2024050310211623800_CIT0045","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa1805453","article-title":"Combined nivolumab and ipilimumab in melanoma metastatic to the brain","volume":"379","author":"Tawbi","year":"2018","journal-title":"N Engl J Med."}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noad236\/56133909\/noad236.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/26\/5\/965\/57393321\/noad236.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/26\/5\/965\/57393321\/noad236.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T10:22:07Z","timestamp":1714731727000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/26\/5\/965\/7467048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,9]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,12,9]]},"published-print":{"date-parts":[[2024,5,3]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noad236","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5,1]]},"published":{"date-parts":[[2023,12,9]]}}}